These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28394260)

  • 21. The activation of peroxisome proliferator-activated receptor γ is regulated by Krüppel-like transcription factors 6 & 9 under steatotic conditions.
    Escalona-Nandez I; Guerrero-Escalera D; Estanes-Hernández A; Ortíz-Ortega V; Tovar AR; Pérez-Monter C
    Biochem Biophys Res Commun; 2015 Mar; 458(4):751-6. PubMed ID: 25686501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Mechanism of Betaine on Hepatic Lipid Metabolism: Inhibition of Forkhead Box O1 (FoxO1) Binding to Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
    Kim DH; Lee B; Kim MJ; Park MH; An HJ; Lee EK; Chung KW; Park JW; Yu BP; Choi JS; Chung HY
    J Agric Food Chem; 2016 Sep; 64(36):6819-25. PubMed ID: 27546313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice.
    Zhang Y; Yu L; Cai W; Fan S; Feng L; Ji G; Huang C
    Sci Rep; 2014 Dec; 4():7375. PubMed ID: 25487878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ.
    Xu E; Forest MP; Schwab M; Avramoglu RK; St-Amand E; Caron AZ; Bellmann K; Shum M; Voisin G; Paquet M; Montoudis A; Lévy E; Siminovitch KA; Neel BG; Beauchemin N; Marette A
    Hepatology; 2014 May; 59(5):1803-15. PubMed ID: 24327268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
    Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
    J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
    Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-carnitine ameliorates the liver inflammatory response by regulating carnitine palmitoyltransferase I-dependent PPARγ signaling.
    Jiang F; Zhang Z; Zhang Y; Wu J; Yu L; Liu S
    Mol Med Rep; 2016 Feb; 13(2):1320-8. PubMed ID: 26647854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
    Jia Y; Wu C; Kim J; Kim B; Lee SJ
    J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
    Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
    Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.
    Inoue M; Ohtake T; Motomura W; Takahashi N; Hosoki Y; Miyoshi S; Suzuki Y; Saito H; Kohgo Y; Okumura T
    Biochem Biophys Res Commun; 2005 Oct; 336(1):215-22. PubMed ID: 16125673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha.
    Piessen G; Jonckheere N; Vincent A; Hémon B; Ducourouble MP; Copin MC; Mariette C; Van Seuningen I
    Biochem J; 2007 Feb; 402(1):81-91. PubMed ID: 17037983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.
    van der Leij FR; Bloks VW; Grefhorst A; Hoekstra J; Gerding A; Kooi K; Gerbens F; te Meerman G; Kuipers F
    Genomics; 2007 Dec; 90(6):680-9. PubMed ID: 17933490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
    Finck BN; Gropler MC; Chen Z; Leone TC; Croce MA; Harris TE; Lawrence JC; Kelly DP
    Cell Metab; 2006 Sep; 4(3):199-210. PubMed ID: 16950137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.
    Schadinger SE; Bucher NL; Schreiber BM; Farmer SR
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1195-205. PubMed ID: 15644454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
    Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
    Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A conditional model reveals that induction of hepatocyte nuclear factor-1alpha in Hnf1alpha-null mutant beta-cells can activate silenced genes postnatally, whereas overexpression is deleterious.
    Luco RF; Maestro MA; del Pozo N; Philbrick WM; de la Ossa PP; Ferrer J
    Diabetes; 2006 Aug; 55(8):2202-11. PubMed ID: 16873682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic HNF1 transcription factors control the induction of PCSK9 mediated by rosuvastatin in normolipidemic hamsters.
    Dong B; Singh AB; Shende VR; Liu J
    Int J Mol Med; 2017 Mar; 39(3):749-756. PubMed ID: 28204827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta.
    Saji T; Kikuchi R; Kusuhara H; Kim I; Gonzalez FJ; Sugiyama Y
    J Pharmacol Exp Ther; 2008 Feb; 324(2):784-90. PubMed ID: 18029548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.